What's the Cost of Retinoblastoma Diagnosis and Treatment in India?
Retinoblastoma treatment cost in India runs from Price on request to Price on request for complex care. Essential procedures like enucleation of the eye cost AUD $4,800 to AUD $7,200, while intra-arterial chemotherapy ranges from AUD $6,800 to AUD $11,300. Total costs depend on the cancer stage and hospital tier. Families often save 70โ80% compared to Australia. Delhi, Bengaluru, and Chennai are the top cities for this treatment.
Typical Retinoblastoma Treatment Costs in India
- Complex treatment of retinoblastoma: Price on request
- Intra-arterial chemotherapy: AUD $6,800 โ AUD $11,300
- Enucleation of eye: AUD $4,800 โ AUD $7,200
- Cryotherapy: AUD $900 โ AUD $2,000
- Photocoagulation: AUD $380 โ AUD $980
- Removal of part of tumor and nerve of eye: AUD $4,200 โ AUD $8,300
- High intensity focused ultrasound ablation (HIFU): AUD $6,800 โ AUD $10,200
Bookimed Expert Insight: Advanced cases often suit multidisciplinary centres with JCI accreditation. Fortis Gurgaon ranks as a technically advanced facility for complex robotic-assisted oncology. For specialised eye care, Centre For Sight has received multiple excellence awards for its focused ophthalmic expertise. Large networks like Manipal Hospitals treat over 2,000,000 patients annually. They provide 50+ years of clinical experience for families needing long-term cancer management.
| India | Thailand | Turkey | |
|---|---|---|---|
| Radiation therapy for colorectal cancer | โ AUD $6,800 | โ AUD $11,300 | from AUD $9,000 |
| Photocoagulation | โ AUD $380 | โ AUD $680 | from AUD $450 |
| High intensity focused ultrasound ablation (HIFU) | โ AUD $6,800 | โ AUD $9,000 | from AUD $9,000 |
| Enucleation of eye | โ AUD $4,800 | โ AUD $6,300 | from AUD $2,700 |
| Chemotherapy for breast cancer | โ AUD $4,800 | โ AUD $7,500 | from AUD $7,100 |
Your Benefits and Guarantees with Bookimed
Transparent Prices & Flexible Installments
No hidden fees โ just official clinic prices. Pay at the clinic for Retinoblastoma treatment and use a flexible instalment plan if needed.
Verified Clinics & Doctors Only
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Retinoblastoma treatment and have the necessary licenses to serve international patients worldwide.
Free 24/7 Assistance
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Retinoblastoma treatment journey.

Your personal Bookimed medical coordinator
- Supports you at every stage
- Helps choose the right clinic and doctor
- Ensures quick and convenient access to information
Best Retinoblastoma Treatment Centres in India for Australians: 9 Verified Options and AUD Prices
Global Hospital Chennai
Sandeep Attawar








HCG Manavata Cancer Centre
Raj Nagarkar




Get a Medical Assessment for Retinoblastoma in India: Consult with Experienced Doctors Now
View all Doctors
Raj Nagarkar
Dr. Raj Nagarkar has performed over 50,000 cancer surgeries at HCG Manavata Cancer Centre. He specializes in breast and thoracic surgical oncology. Dr. Nagarkar trained at the prestigious Tata Memorial Hospital in Mumbai. He is a Member of the Royal College of Surgeons in Edinburgh.
- Participated as a lead investigator in more than 200 clinical trials.
- Serves as a professor for DNB Superspecialty Surgical Oncology.
- Expert in complex procedures including mastectomy and thoracic resections.
- Founder of Curie Manavata Cancer Centre, a major regional treatment hub.

Deenadayalan Munirathnam
The doctor is a pediatric hematologist-oncologist with a specialization in bone marrow transplantation. They have extensive experience in treating complex blood disorders and cancers in children. Their clinical focus includes the management of pediatric leukemia, lymphoma, and other hematologic malignancies. The doctor is recognized for their expertise in performing bone marrow transplants and has contributed to advancements in pediatric oncology through clinical research and innovation.

Varun Malhotra
Dr. Varun Malhotra is an ophthalmologist at Centre For Sight in Delhi. He completed the Sir Ratan Tata Fellowship in microincision cataract surgeries. He specializes in cornea, anterior segment, and refractive surgery. Dr. Malhotra trained at Sankara Nethralaya and LV Prasad Eye Institute.
- Trained in refractive surgery under Dr. Rupal Shah, a global subject authority.
- Completed a specialized Zeiss-Ophthalmic Diagnostics fellowship for precise eye mapping.
- Formerly served as a consultant at Anand Eye Institute and Pushpagiri Eye Institute.
- Practices at Centre For Sight, a multi-award-winning eye care network in India.

Sandeep Attawar
Dr. Sandeep Attawar is a cardiothoracic surgeon who has performed 10,000+ heart surgeries. He serves as the Director of the Lung Transplant Program at Gleneagles Global Health City. Dr. Attawar specializes in complex heart and lung transplants for both adults and children. He maintains an 85โ90% success rate for thoracic organ transplant procedures.
- Member of the International Society for Heart and Lung Transplantation.
- Expertise includes mechanical circulatory support and pediatric cardiac surgery.
- Holds membership in the European Association for Cardio-Thoracic Surgery.
- Works at a clinic recognized among the World's Best Smart Hospitals by Newsweek.
Share this content
Video Stories from Bookimed Patients
Anna Leonova
Expert Overview about Retinoblastoma Treatment in India
What is the success rate of retinoblastoma treatment in India?
Retinoblastoma treatment in India shows survival rates exceeding 95% when the cancer is diagnosed early. Success depends heavily on the disease stage. Major centres maintain survival figures between 95% and 98% for intraocular cases. When treatment is delayed, survival in advanced cases drops to 40%.
- Early-stage survival: Patients with intraocular tumours achieve survival rates between 95% and 98%.
- Advanced survival: Extraocular or metastatic cases report survival drops to between 40% and 60%.
- Eye salvage: Conservative treatments save the eye in 85% to 95% of early-stage cases.
- Late-stage salvage: Advanced tumours (Group D/E) see eye preservation rates fall between 20% and 40%.
Bookimed Expert Insight: Retinoblastoma success in India relies on dedicated paediatric oncology units rather than general clinics. HCG Manavata Cancer Centre serves over 75,000 patients annually. It houses a specialist paediatric oncology department. This specific infrastructure, combined with technologies like Versa HD radiotherapy, enables precise dosing in children. Precise dosing is critical for maintaining survival while minimising long-term side effects.
Patient Consensus: Patients note that advanced Group E cases often achieve nearly 100% survival through enucleation. This is true even if the eye cannot be saved. Families emphasise that intra-arterial chemotherapy shrinks tumours. However, maintaining functional vision remains a separate challenge from simply curing the cancer.
What are the best hospitals for retinoblastoma treatment in India?
Leading Indian hospitals for retinoblastoma include JCI-accredited Apollo Hospital Indraprastha and BLK Super Speciality Hospital. Both are in Delhi. These centres provide multidisciplinary care combining paediatric oncology and ophthalmology. Facilities like HCG Manavata Cancer Centre offer radiotherapy units specifically for complex paediatric cases.
- Clinic accreditation: Apollo Hospital and Artemis Hospitals hold JCI accreditation for international safety standards.
- Specialised units: HCG Manavata Cancer Centre features a dedicated paediatric oncology unit for eye cancers.
- Large networks: Manipal Hospitals serves 2,000,000 patients annually through a vast specialist medical network.
- Technology: Centres like Fortis Gurgaon rank among the most technically advanced hospitals globally.
Bookimed Expert Insight: Retinoblastoma remains a rare speciality in India. While many multi-speciality clinics exist, focusing on centres like HCG Manavata Cancer Centre is wise. They treat over 75,000 oncology patients annually and use Versa HD Radiotherapy. This specific high-volume experience with children helps when managing delicate ocular oncology cases.
Patient Consensus: Patients note that comprehensive eye cancer services are rare in India. So, finding a hospital with a dedicated paediatric team is essential. Families often prioritise clinics offering interventions like intra-arterial chemotherapy to improve outcomes.
What treatment options are available for retinoblastoma in India?
Comprehensive retinoblastoma care in India focuses on eye preservation. It uses intra-arterial chemotherapy, plaque brachytherapy, and focal therapies like cryotherapy. Centres such as HCG Manavata Cancer Centre and Apollo Hospital Indraprastha use intensive multidisciplinary protocols. These specialised treatments help achieve 95% eye preservation when detected early.
- Intra-arterial chemotherapy: Delivers high-dose medication directly to the eye, sparing healthy organs.
- Focal therapies: Uses cryotherapy or laser photocoagulation to destroy small, localised retinal tumours.
- Plaque brachytherapy: Applies a radioactive disc to the eye wall for targeted radiation.
- Surgical enucleation: Provides nearly 100% cancer elimination for advanced cases where preservation is impossible.
Bookimed Expert Insight: Retinoblastoma cases in India often involve advanced stages. Yet centres like HCG Manavata Cancer Centre maintain high capacity, having performed 65,000+ cancer surgeries. Patients should prioritise NABH-accredited facilities, as India's specialised ocular oncology network aims for 95% globe preservation. Standardised chemotherapy for bilateral cases commonly uses vincristine and carboplatin to minimise drug-related complications.
Patient Consensus: Seeking survivor support helps manage the isolation of this rare condition. Families emphasise that strictly following surgery counselling and follow-up schedules is vital. This helps prevent the cancer from spreading to the brain. In India, intra-arterial chemotherapy is a valued option. However, survivors note that eye preservation does not always guarantee full vision.
How long does the treatment process for retinoblastoma in India take?
Retinoblastoma treatment in India typically starts with a 2 to 3-week intensive phase. This phase covers diagnosis and initial therapy. Complete treatment cycles, including intra-arterial chemotherapy or radiation, often span 5 to 8 months. Early intervention achieves a 95% eye preservation rate at JCI-accredited Indian centres.
- Initial phase: Registration and first chemotherapy cycles occur within 1โ5 days of arrival.
- Chemotherapy duration: Cycles are repeated every few weeks, lasting up to 8 months.
- Radiation schedule: Treatment often involves 20 fractions delivered over a strict 5-week period.
- Treatment technologies: Specialised units like HCG Manavata use TomoTherapy-H for precise paediatric radiotherapy.
Bookimed Expert Insight: Retinoblastoma cases in India benefit from massive clinical volume. Centres like Apollo Hospital Indraprastha and HCG Manavata serve over 75,000 to 1,000,000 patients annually. This high turnover means oncology teams manage rare paediatric tumours with high precision. For Australian families, this volume means specialists have handled hundreds of similar cases. They have used modern equipment like Versa HD Radiotherapy.
Patient Consensus: Patients note that early intervention in India can save 95% of children's eyes. Success relies on strict adherence to schedules. Skipping appointments can lead to rapid tumour growth within months. Intra-arterial chemotherapy may take a year for full stability. However, most find the process highly efficient.
Is genetic counselling available for families considering retinoblastoma treatment in India?
Genetic counselling is widely available at major Indian eye care and oncology centres. Hospitals use genetic testing to identify RB1 gene mutations. This helps specialists determine if the retinoblastoma is hereditary. It also guides screening for siblings and future family planning.
- Certified laboratories: NABL-accredited labs at Manipal Hospitals have the technical competence needed for complex genetic testing.
- Clinical oversight: JCI-accredited facilities like Apollo Hospital Indraprastha follow international safety standards for diagnostics.
- Specialised oncology: HCG Manavata Cancer Centre focuses on paediatric oncology and uses US-FDA-audited research standards.
- Diagnostic infrastructure: BLK Super Speciality Hospital employs modern diagnostic equipment to identify specific hereditary markers.
Bookimed Expert Insight: Retinoblastoma centres in India, such as HCG Manavata, manage extremely large patient volumes. They serve over 75,000 patients annually. This high-volume environment helps ocular oncologists quickly identify hereditary patterns. These patterns might be missed in smaller clinics. Families should look for centres with NABL-accredited labs. Their labs make sure genetic results meet Australian standards for follow-up care.
Patient Consensus: Genetic testing is essential because up to 40% of cases are hereditary. Patients note that bringing Australian genetic reports to India can speed up the planning. This helps with sibling screening.













